Having trouble accessing articles? Reset your cache.

Niraparib: Phase I/II data

Data from 11 evaluable patients with platinum-sensitive, high-grade serous or endometrioid ovarian cancer in the open-label, Danish Phase

Read the full 189 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE